Insider trades
Metzger Michael A., CEO of Syndax Pharmaceuticals SNDX, has filed 0 purchases and 8 sales on the open market. Over the past 12 months that comes to a net sale of $643.7K. The latest trade was on 06/01.
Metzger Michael A.
CEO
- Company
- Syndax Pharmaceuticals SNDX
- First filing
- 23/02/03
- Trades
- 36 trades
- Buys / sales
- 0 / 8
- 12-month net buying
- −$643.7K
- Last trade
- 06/01
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale | 06/01 | 06/02 | 6,847 sh | $18.99 | $130,024.53 | −1.4% | |
| Open-market sale | 02/09 | 02/10 | 17,159 sh | $21.03 | $360,853.77 | −3.4% | |
| Open-market sale | 02/06 | 02/06 | 7,412 sh | $20.62 | $152,835.44 | −1.4% | |
| Open-market sale10b5-1 plan | 25/09/08 | 25/09/08 | 157,307 sh | $16.41 | $2,581,407.87 | −34.5% | |
| Open-market sale | 25/07/16 | 25/07/18 | 7,534 sh | $9.29 | $69,990.86 | −2.5% | |
| Open-market sale10b5-1 plan | 25/03/04 | 25/03/06 | 7,814 sh | $15.05 | $117,600.7 | −2.5% | |
| Open-market sale | 25/02/10 | 25/02/12 | 13,288 sh | $15.50 | $205,964 | −4.2% | |
| Open-market sale | 23/02/06 | 23/02/08 | 5,959 sh | $27.64 | $164,706.76 | −25.2% |